Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters

• Main Authors: Rana Abdelnabi (Author), Piet Maes (Author), Steven de Jonghe (Author), Birgit Weynand (Author), Johan Neyts (Author)
• 格式: 圖書
• 出版: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Remdesivir was the first antiviral drug to be approved for the treatment of severe COVID-19; followed by molnupiravir (another prodrug of a nucleoside analogue) and the protease inhibitor nirmatrelvir. Combination of antiviral drugs may result in improved potency and help to avoid or delay the devel...